ABSTRACT Two trials were conducted to assess the fate of the Cry3Bb1 protein from YieldGard rootworm corn (MON 863) when fed to laying hens. In the first trial, 2 diets, 1 formulated with MON 863 and 1 with conventional corn, were fed to laying hens (12 replicate cages with 4 hens/cage per treatment) for 8 wk. Daily feed intake (FI), egg production (EP), and BW were measured. Prestudy fecal samples, wk 4 and 8 egg and fecal samples, and hepatic and pectoralis tissue samples were collected from 12 killed hens and were tested for the Cry3Bb1 protein. Corn source had no significant effects on FI, EP, or BW. Feces from hens fed diets containing MON 863 were positive for the Cry3Bb1 protein or proteolytic fragments (1.5 to 4.0 ppm fecal dry matter). The Cry3Bb1 protein could not be determined in eggs due to the presence of an interfering substance in all test and control
INTRODUCTION
Insect-resistant corn, MON 863, produces a variant of the Bacillus thuringiensis Cry3Bb1 protein. The MON 863 plants are resistant to the larval feeding damage of the coleopteran insect, corn rootworm (Coleoptera, Chrysomelidae, Diabrotica sp.). The digestibility of Cry3 proteins has been thoroughly evaluated in vitro (OECD, 2007) and as part of the safety assessment requirements for product registration with the US Environmental Protection Agency and Food and Drug Administration. The Cry proteins, including Cry3Bb1, are unstable in simulated gastric conditions and are rapidly degraded by pepsin (FSANZ, 2005) . When exposed to intestinal digestive enzymes such as trypsin and chymotrypsin, however, Cry proteins are characterized to partially degrade to a smaller, stable form described as the trypsin-resistant core (FSANZ, 2005) . Stability to trypsin and trypsin-like prote-©2008 Poultry Science Associaton Inc. Received October 18, 2007 . Accepted February 20, 2008 Corresponding author: sscheideler1@unl.edu 1089 eggs. No Cry3Bb1 protein was detected in hepatic and pectoralis tissue. In the second trial, the same test and control diets were fed to 12 hens each. Six hens/treatment were sampled after 7 and 28 d. Samples included blood, feces, and digesta (crop, small and large intestine, and ceca). The Cry3Bb1 protein could not be determined in blood due to the presence of an interfering substance in all test and control blood samples. The Cry3Bb1 protein or partially digested fragments, or both, were found in the digesta sampled from all sections of the digestive tract. About 98 to >99% of the dietary Cry3Bb1 protein was digested. Overall, MON 863, when fed to laying hens, had no significant effects on FI, EP, or BW. The Cry3Bb1 protein was extensively digested, similar to that of other dietary proteins, and was not detected in hepatic or muscle tissue.
ases is a predictable phenomenon for Cry proteins (Hö fte and Whiteley, 1989; Rajamohan et al., 1998; Rukmini et al., 2000; Aronson and Shai, 2001; OECD, 2007) . When Escherichia coli-produced Cry3Bb1 variant protein was produced and administered by gavage to mice at doses of 300, 900, and 2,700 mg/kg of BW, no animal deaths, no significant clinical observations, and no BW changes or gross internal findings were observed after 14 d (FSANZ, 2005) . The present study was designed to evaluate the in vivo digestibility of the Cry3Bb1 protein present in MON 863 corn grain when fed to laying hens.
MATERIALS AND METHODS

Laying Hens and Housing
The study was conducted in accordance with the University of Nebraska Animal Care Committee. In experiment 1, 96 Dekalb (Centurian Poultry Inc., Bogart, GA) White Leghorn laying hens (24 wk of age) that had been laying for 4 wk before the start of the study were used. Birds were housed in cages (45.7 cm × 50.8 cm) with 4 birds/cage in an environmentally controlled facility starting at 16 wk of age and used in the study when they were 24 wk old. Assignment of treatments to cages was conducted using a computer random number generator utilizing a randomized complete block design. Blocks were 12 consecutive cages on 1 row and deck in a 4-tiered Farmer Automatic (Farmer Automatic of America, Register, GA) stacked deck caging system.
In experiment 2, twenty-four Dekalb White Leghorn laying hens were used. Birds were housed individually in cages (45.7 cm × 50.8 cm) in an environmentally controlled facility. Assignment of treatments to cages was conducted using a computer random number generator utilizing a randomized design. There were 12 consecutive cages on 1 row and deck in a 4-tiered Farmer Automatic stacked deck caging system.
Environmental conditions for the hens (i.e., floor space, temperature, lighting, animal density, feeder and water space) were similar for all experimental groups. Feed and water were provided ad libitum throughout the trial.
Experimental Design
Experiment 1. A randomized complete block design was used with 2 dietary treatments with 12 replicate cages containing 4 birds each (48 birds/treatment). The diets were fed for 8 wk.
Experiment 2. A completely randomized design was used with 2 dietary treatments with 12 replicate cages containing 1 bird/cage (12 birds/treatment). The diets were fed for 4 wk.
Corn
The MON 863 (corn grain lot GLP-0303-13756-S) and the near-isogenic control (lot 13758-S) were obtained from Monsanto Company (St. Louis, MO) and shipped to the University of Nebraska. Before the start of the study, MON 863 and control corn were sampled and checked for Cry3Bb1 protein using Cry3Bb1 lateral flow test strips (Strategic Diagnostics Inc., Newark, DE).
Diets
Diets were formulated to contain similar concentrations of corn and conform to industry standards or meet or exceed NRC (1994) values for laying hens, or both. The diet compositions are presented in Table 1 . The same diets were used in both experiments.
After the diets were mixed, subsamples were collected and analyzed for Cry3Bb1 protein using Cry3Bb1 lateral flow test strips and for nitrogen, dry matter, total phosphorus, and calcium using AOAC procedures (AOAC, 1999) .
Measurements
Experiment 1. Hens were weighed biweekly, and egg production was measured daily. All feed added and removed from cages was weighed daily. The test facility, cages, and birds were observed twice daily for general Feed intake was recorded daily. After 7 d, 6 hens per treatment were sampled for blood, killed by cervical dislocation, and surgically eviscerated. Blood samples were drawn from the wing using a 20-gauge needle and a 3-mL syringe. Samples were injected into collection tubes containing EDTA. Immediately after collection, test strips were inserted directly into the blood tubes. The crop, small intestine, cecum, and large intestine were excised from each hen, and digesta samples were taken from each section. Digesta samples were tested for the presence of Cry3Bb1 protein using Cry3Bb1 lateral flow test strips. The remaining birds were sampled and tested, as described, at the end of the 4-wk period.
Samples and Processing
Corn Grain Extraction. Samples of grain used to formulate the test and control diets were ground in a mortar and pestle, transferred to tared vials, and mixed with PBS at a rate of 3 mL/g of corn. Each vial was mixed for 20 min on a shaker. Extracts were clarified by centrifugation for 10 min at 4°C. The resulting supernatants were transferred to fresh vials and analyzed using Cry3Bb1 lateral flow test strips.
Diet Extraction. Samples of the formulated test and control diets were collected, as well as the basal diet fed to hens before the start of the study. Diet samples (0.5 to 2 g) were transferred to tared vials and mixed with PBS at a rate of 3 mL/g of diet. Each sample was then pro- Correlates with basal diet spiked with 0.5% (wt/wt) to 1% (wt/wt) test diet.
cessed as described for corn grain and analyzed using Cry3Bb1 lateral flow test strips. The control diet contamination level was semiquantitatively estimated by comparison to extracts containing known amounts of test diet spiked into basal diet. A titration curve containing 0, 0.5, 1.0, and 2.0% (wt/wt) test diet spiked into basal diet was prepared and analyzed using Cry3Bb1 lateral flow test strips.
Collection of Feces. To ensure that the collected feces were not contaminated with diet(s), diets were removed and clean collection trays placed under each cage approximately 24 h before feces collection. On the day of collection, feathers were removed from the trays, and feces were transferred into labeled containers. The feces were mixed and representative samples (12 control and 12 test samples) transferred to labeled collection tubes and promptly frozen on dry ice. All samples were shipped frozen on dry ice from the University of Nebraska to Monsanto Company and stored in a −80°C freezer until extracted.
Feces and Digesta Extraction. The fecal and digesta collection tubes were placed on dry ice, and a portion (approximately 1 g) of each was transferred to tared vials. Deionized water was added at a rate of 1.5 mL/g of feces, and the vials were placed at room temperature. Each vial was mixed for 20 min on a shaker. Extracts were clarified by centrifugation for 30 min at 4°C. The resulting supernatants were transferred to fresh vials and stored, or mixed with 5 × SDS-PAGE sample buffer [312 mM Tris, pH 6.8, 10% (wt/vol) SDS, 25% (vol/vol) 2-mercaptoethanol, 50% (vol/vol) glycerol, and 0.5% (wt/vol) bromophenol blue] at a ratio of 1 part 5 × sample buffer to 4 parts extract and stored frozen in a −20°C freezer until analysis.
Hepatic Samples. One hen was randomly selected from each pen and killed. Fresh liver samples were manually extracted from the killed hens. The samples were immediately placed in Whirl-Pak bags and frozen. Before analysis, samples were thawed and homogenized in 125 mL of distilled water using a blender. A portion of the homogenate (5 mL) was centrifuged for 20 min, and 0.5 One hen was randomly selected from each pen and killed. Fresh breast muscle samples were manually extracted from the killed hens. The samples were immediately placed in Whirl-Pak bags and frozen. Before analysis, samples were thawed and homogenized in 140 mL of distilled water using a blender. A portion of the homogenate (5 mL) was centrifuged for 20 min, and 0.5 mL of supernatant was transferred to a microcentrifuge tube with a Cry3Bb1 lateral flow test strip.
Egg Samples. Two eggs per replicate pen were sampled at 4 and 8 wk. Eggs were homogenized, and 0.5 mL of the liquid egg sample was transferred directly to a microcentrifuge tube with a Cry3Bb1 lateral flow test strip.
Reference Protein. The Cry3Bb1 reference protein (Monsanto lot 20-100044) was produced and isolated from E. coli by Monsanto Company. The lot was previously characterized (7.6 mg/mL of total protein, 83% pure) and was used as a quantitative molecular weight marker on Western blots. The trypsin-resistant core was produced by incubating Cry3Bb1 reference protein (2 g) with fecal extract (50 L) obtained from hens fed control diet (time 0) and diluted to 800 L with water. The mixture was incubated overnight at room temperature and diluted to a final total protein concentration of 0.04 ng/ L in 1 × SDS-PAGE sample buffer. The purity correction factor of 0.83 was applied after loading all gels.
Sample Analysis
Cry3Bb1 Lateral Flow Test Strips. Extracts were evaluated for the presence of Cry3Bb1 protein using double antibody sandwich format lateral flow test strips (part number 7000041, Strategic Diagnostics Inc.). Test strips used to evaluate gastrointestinal tract digesta samples, feces, liver, blood, and egg samples were developed for Laemmli (1970) , using 12-well, 1-mm, 4 to 20% polyacrylamide gradient Tris-glycine mini gels (Invitrogen, Carlsbad, CA). Colored markers (Bio-Rad, Hercules, CA) were included in all gels and used to verify electrotransfer of protein and to calibrate the blots. Electrotransfer to polyvinylidene fluoride membranes was performed for 75 min at 300 mA in Hoefer Inc. (San Francisco, CA) transfer units chilled to 4°C. All incubations and wash steps were performed at room temperature with gentle shaking. Membranes were blocked by incubation in 5% (wt/vol) nonfat dry milk (NFDM) in PBS containing 0.05% (vol/vol) Tween-20 (PBST) detergent for 1 h. Polyclonal goat anti-Cry3Bb1 IgG (Monsanto lot 6844572) was used to probe the membrane for 1 h at a dilution of 1:3,000 in 1% (wt/vol) NFDM in PBST. Excess serum was removed by four 5-min washes with PBST. The secondary antibody solution was preincubated with rabbit serum for 1 h to reduce background signals. To probe for bound IgG, the membranes were incubated with a solution containing rabbit anti-goat IgG, peroxidase conjugate (Sigma, St. Louis, MO) at a dilution of 1:5,000, 10% (vol/vol) rabbit serum (Sigma), and 1% (wt/ vol) NFDM in PBST, for 1 h, and again washed with PBST (four 5-min washes). Immunoreactive bands were visualized using the enhanced chemiluminescence detection system (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) and exposed (1 and 4 min) to Hyperfilm enhanced chemiluminescence high performance chemiluminescence film (Amersham Biosciences). Films were developed using a Konica SRX101A automated film processor (Tokyo, Japan). All protein estimates were made from using films exposed for 1 min.
Densitometric Estimation of Cry3Bb1 Protein in Fecal Extracts. Immunoreactive signals were quantitated using a Bio-Rad GS-800 calibrated densitometer. Densitometric quantities of unknowns were selected as rectangles encompassing the 57-kDa trypsin-resistant band (when observed) or the region of the lane corresponding to 57 kDa (when no band was observed). An empty region of each blot was selected as background, and subtracted from all unknown and known sample values. All densitometric values were expressed as adjusted optical density per mm 2 . Fecal Dry Matter Determination. Four clean 50-mL Pyrex beakers were placed in a forced-air oven set at 60°C to thoroughly dry. Fecal samples (2 control diet and 2 test diet groups, ranging from 2.9 to 3.2 g) were weighed into tared beakers and heated at 60°C until the weight of the container was constant (approximately 24 h). The percentage of dry matter was calculated as an average of the 4 sample values.
Statistical Analysis
Statistical analyses were conducted using the repeated measures MIXED model procedure of SAS (SAS Institute Inc., Cary, NC). Parameters included feed intake (g/hen per day), egg production (%hen/day), and BW (kg).
RESULTS
Detection of Cry3Bb1 ProteinExperiment 1
Corn and diet samples were evaluated for the presence of the Cry3Bb1 protein using Cry3Bb1 lateral flow test strips. The results are summarized in Table 2 . No Cry3Bb1 protein was detected in the basal diet fed to hens before the start of the study. The conventional grain used to formulate the control diet was negative for the Cry3Bb1 protein. The MON 863 grain used to formulate the test diet was positive for the Cry3Bb1 protein. The test diet was observed to be positive, as expected. However, control diet was observed to be weakly positive for Cry3Bb1 protein apparently from contamination during the mixing process.
To determine the level of commingling of test grain in the control diet, a titration curve was prepared using mixtures of basal diet, which was shown to be negative for the Cry3Bb1 protein, and test diet. The relative color intensity observed on the lateral flow test strip for the control diet was compared with test strips incubated with a known amount of test diet spiked into basal diet. The color intensity that developed for the control diet was greater relative to the test strip spiked with 0.5% (wt/ wt) test diet and weaker relative to the test strip spiked with 1% (wt/wt) test diet.
Results of the testing for the presence of Cry3Bb1 protein in liver, breast meat, and feces are presented in Table  3 . All eggs appeared to test positive regardless of the diet. Eggs were subsequently purchased from a supermarket (Lincoln, NE) and also all appeared to test positive, indicating that an interfering substance was present in the egg. Therefore, the results for detection of Cry3Bb1 protein in egg were inconclusive. All hepatic and breast muscle samples were negative for Cry3Bb1 protein (Table 3) . Feces from birds fed the control corn were 100% negative for the presence of Cry3Bb1 protein at 0 and 4 wk; fecal samples from the birds fed the MON 863 corn containing Cry3Bb1 protein were negative at 0 wk but were positive at the 4-and 8-wk sampling times.
Two fecal extracts collected at 8 wk tested positive from hens fed the control diet (Table 3) . Quantitative Western blots were used to assess the amount and intactness of the Cry3Bb1 protein in fecal extracts.
The Cry3Bb1 reference protein was used as a quantitative molecular weight marker on Western blots. The Cry3Bb1 reference protein was mixed with feces extract from hens fed control diet in an attempt to eliminate any effect(s) the extract may have on the mobility of the reference protein. Interestingly, in the presence of feces extract, the reference protein was observed to degrade from the full-length size of 74 kDa to smaller fragments with approximate molecular weights of 68 and 57 kDa (Figure 1) .
Because 2 immunoreactive bands (68 and 57 kDa) were observed in the Cry3Bb1 reference protein incubated with control fecal extract, the densitometric sum of these 2 bands was used at each titration point for purposes of quantifying the level of Cry3Bb1 protein in the sample (Figure 2 ). Densitometric data from lanes D5 and D6 were omitted from analysis, because they were outside the linear range of the film. Data from lanes D1 through D4 were used to generate a standard curve that yielded an R 2 value of 0.97, when fit to a linear equation. The amount of Cry3Bb1 protein observed in fecal extracts was calculated from the standard curve. The limit of detection for Cry3Bb1 reference protein spiked into a fecal extract obtained from hens fed control diet was defined as the lowest amount loaded, or 0.02 ng. To compensate for blotto-blot variability, a known amount of Cry3Bb1 reference protein was included on all Western blots. The data were normalized to the Cry3Bb1 reference protein (loaded at 0.3 ng).
Western blot analyses of fecal extracts from hens fed test diets are shown in Figure 3 . Consistent with the lateral flow test strip results, no immunoreactive band corresponding to the trypsin-resistant core (57 kDa) was observed at time 0 for extracts of test diet feces. All fecal extracts collected at 4 and 8 wk contained some level of the Cry3Bb1 trypsin-resistant core. No full-length Cry3Bb1 protein or intermediately stable 68-kDa Cry3Bb1 fragment was observed in fecal extracts from hens fed test diet. The amount of Cry3Bb1 protein detected in these samples was estimated by comparison to the titration curve generated using the reference protein (Figure 2) . Two test diet fecal extracts were omitted from the densito- metric analysis (Figure 3 , T10/8 wk, and T11/time 0) due to the high background levels observed in these samples. Western blot analyses of fecal extracts from hens fed control diet (Figure 4) were consistent with the lateral flow test strip results. No detectable Cry3Bb1 trypsinresistant core was observed in fecal extracts at time 0. The 2 lateral flow test strips samples that were positive for Cry3Bb1 protein correspond to the Western blot lanes designated as C8/8-wk and C9/8-wk extracts (Figure 4) . A faint band is observed at approximately 57 kDa in these 2 lanes, consistent with the lateral flow test strip results. No detectable Cry3Bb1 trypsin-resistant core was observed in fecal extracts from all other hens fed the control diet. All control diet fecal extracts were analyzed in the same manner as the test diet samples. Two control diet fecal extracts were omitted from the densitometric analysis (C6/time 0 and C8/time 0) due to the high background levels observed in these samples. Variable amounts of trypsin-resistant core Cry3Bb1 protein were detected in fecal extracts from hens fed the test diet. The amount ranged from approximately 0.1 to 0.6 ppm. The overall average amount of trypsin-resistant core Cry3Bb1 protein detected in all fecal extracts from hens fed test diet was 0.22 ppm.
Production Data -Experiment 1
Feed intake, egg production, and BW for each of the 8 wk of experiment 1 are presented in Table 4 . No differences (P > 0.05) were detected in feed intake, egg production, or BW between birds fed corn grain containing the Cry3Bb1 protein versus birds fed the control corn grain during the 8-wk trial.
Detection of Cry3Bb1 ProteinExperiment 2
Results of the detection of Cry3Bb1 protein in gastrointestinal tract digesta samples and feces are presented in Table 5 . At d 7 and 28 sampling periods, Cry3Bb1 protein or its fragments were detected in each of the sections in the digestive tract for the birds fed test diet, whereas none were detected in the digesta from birds fed the control diet. All blood samples, regardless of diet, appeared to test positive for the Cry3Bb1 protein or its fragment(s) indicating the presence of an interfering substance with the assay (similar to the egg protein detection results). Therefore, the blood sample results were inconclusive and not included in Table 5 .
DISCUSSION
The in vivo digestibility of the Cry3Bb1 protein in MON 863 corn grain was evaluated in laying hens. The test diet tested positive for Cry3Bb1 protein, as expected. However, additional testing was performed, because Cry3Bb1 protein was also detected in the control diet. Known amounts of test diet were mixed with the prestudy basal diet. On the assumption that the Cry3Bb1 protein is equally extractable from basal diet as it is from test diet, this experimental design eliminated the need to know the extractability of the Cry3Bb1 protein and for a pure protein standard. The control diet was determined to contain <1% (wt/wt) contamination. The contamination apparently occurred during diet formulation. However, the contamination level was considered to be low, and the study was allowed to proceed.
Production Performance. Feed intake, egg production, or BW were not different between laying hens fed diets containing Cry3Bb1 protein versus conventional corn grain. Similarly, in broilers, Taylor et al. (2003) reported no differences in performance or carcass parameters. Others feeding soybean meal containing the CP4 EPSPS protein (Ash et al., 2003) to laying hens or corn grain containing Bacillus thuringiensis proteins such as Cry34Ab1 and Cry35Ab1 (Jacobs et al. 2007 ) to chickens or Cry1Ab over 10 generations to quail (10 × 12 wks) and 4 generations to laying hens (4 × 31 wk; Flachowsky et al., 2007) reported no significant effects on animal health, feed intake, feed efficiency, laying performance, or hatchability. Meat and egg quality were also not affected.
Tissue Analyses. No Cry3Bb1 protein was detected in hepatic or breast muscle samples in laying hens in this study. The results for the egg and blood were inconclusive, because there appeared to be an interfering substance with the assay. Jennings et al. (2003) reported no detection of Cry1Ab protein in the breast muscles of broilers fed diets containing MON 810 corn grain. Ash et al. (2003) reported no detection of CP4 EPSPS protein in the whole egg, albumin, or liver of laying hens fed diets containing Roundup Ready soybean meal.
Fecal Analyses. The Cry3Bb1 protein was not detected in feces collected at time 0, using lateral flow test strips. Two extracts collected at 8 wk tested positive from hens fed the control diet. This observation was attributed to contamination, perhaps due to spillage of test diet from a neighboring cage. The Cry3Bb1 protein was detected in the feces of all hens fed test diet collected at 4 and 8 wk. These data suggested that some level of Cry3Bb1 protein, which retained immunological reactivity with the detection antibodies in the lateral flow test strips, escaped digestion in hens fed the test diets. Quantitative Western blot analyses were performed to further evaluate the abundance and intactness of the Cry3Bb1 protein in fecal samples.
The Cry3Bb1 reference protein, when mixed with feces extract from hens fed control diet, was observed to partially degrade (Figure 1 ). The in vitro degradation pattern of Cry3Bb1 protein in simulated intestinal fluid has been previously established by Monsanto Company as part of the safety assessment studies submitted to regulatory agencies (OECD, 2007) . The 68-kDa fragment is known to be intermediately stable to trypsin, and the 57-kDa fragment corresponds to the trypsin-resistant core. This indicates that the fecal extracts contain active trypsin or trypsin-like proteases. Although the Cry3Bb1 reference protein was readily detected using Western blot analysis, high background levels were present in lanes containing fecal extracts (Figure 1, panel A) . As demonstrated in panel B, the origin of the background signal is due to nonspecific interaction(s) with the secondary detection antibody (rabbit anti-goat horseradish peroxidase-conjugate). Unsuccessful attempts to reduce the background level were made, including preincubation of the secondary antibody with rabbit serum. Although the high background level was not desirable, the remaining fecal extracts were analyzed using the same Western blot conditions as shown in Figure 1 , panel A. In one instance, and further confounding interpretation of the Western blots, a dark band was observed in control diet extract very near the size expected for intact Cry3Bb1 protein ( Figure  4 , C11/8 wk). However, this band was attributed to a nonspecific interaction, because the lateral flow test strip result was negative, and the band was present at a position smaller than the intact protein and greater than the intermediately stable trypsin fragment.
The Cry3Bb1 protein detected in fecal extracts from hens fed test diet corresponded to the trypsin-resistant core (57 kDa). The amount detected ranged from approximately 0.1 to 0.6 ppm and averaged 0.22 ppm. To estimate the percentage of Cry3Bb1 protein digestion, the values were expressed on a dry matter basis. The wet feces collected in this study were 15 ± 2% dry matter. Therefore, the amount of Cry3Bb1 protein in dry feces is actually 6.7 times greater than what is observed in the wet fecal extracts (i.e., 1 ÷ 0.15 = 6.7). That is, the detectable amount of Cry3Bb1 protein averaged 1.5 ppm and ranged to 4 ppm on a dry matter basis.
The amount of Cry3Bb1 protein in the test diet can also be calculated on a dry matter basis. The expression level of Cry3Bb1 protein in MON 863 is 70 ppm in the grain on a fresh weight basis or about 80 ppm on a dry matter basis. The test diet was formulated to contain 51% (wt/ wt) grain and therefore contains 41 ppm Cry3Bb1 protein.
The percentage of Cry3Bb1 protein digestion was calculated assuming that 77% of the organic matter (Aulrich et al., 2001 ) and ash were digested leaving 23% of the total feed consumed as fecal dry matter. That is, for each 100 g of diet dry matter consumed, we expect 23 g of fecal dry matter. Using this information and the concentration of Cry3Bb1 protein in test diet (41 ppm) and in feces (1.5 to 4.0 ppm), the digestibility was calculated as follows:
1 − (g of feces × Cry3Bb1 protein concentration in feces) (g of feed consumed × Cry3Bb1 concentration in feed)
× 100 = % Cry3Bb1 protein digested.
Therefore, the Cry3Bb1 protein was calculated to be 98 to 99% digested.
The digestibility of proteins in corn-based poultry diets has been previously reported to range from 84 to 90% (Johnson et al., 1999; Aulrich et al., 2001) . The digestibility of the Cry3Bb1 protein observed in this study was estimated to be from 98 to over 99%, indicating the Cry3Bb1 protein is highly digestible compared to typical dietary protein. The low levels of Cry3Bb1 protein detected in feces were not unexpected in light of the fact that corn is not 100% digested by the bird.
In conclusion, the feeding of laying hens with diets containing MON 863 did not affect the production parameters: feed intake, egg production, or BW compared with birds fed control diets. The Cry3Bb1 protein or protein fragment(s) were detected in digesta and feces but not in hepatic or breast muscle tissues. The small amount of detected protein was expected due to the fact that corn in itself is not totally digested in the laying hen.
